Xenon Pharmaceuticals Inc. Share Price
XENEXenon Pharmaceuticals Inc. Stock Performance
Open $51.53 | Prev. Close $51.40 | Circuit Range N/A |
Day Range $51.37 - $52.25 | Year Range $30.03 - $63.50 | Volume 77,478 |
Average Traded $51.98 |
Xenon Pharmaceuticals Inc. Share Price Chart
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Xenon Pharmaceuticals Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Jun-26 | $51.71 | $52.80 | +3.10% |
08-Jun-26 | $51.90 | $51.21 | -0.95% |
05-Jun-26 | $53.17 | $51.70 | -2.45% |
04-Jun-26 | $53.69 | $53.00 | -0.85% |
03-Jun-26 | $52.60 | $53.45 | +2.22% |
02-Jun-26 | $53.59 | $52.30 | -2.09% |
01-Jun-26 | $53.90 | $53.41 | -2.41% |